HOME
CAREERS
CONTACT US
KOREAN
ENGLISH
KR
EN
Toggle navigation
COMPANY
ABOUT US
KEY MEMBERS
HISTORY
BOARD OF DIRECTORS
SCIENTIFIC ADVISORY BOARD
SCIENCE
PIPELINE
COLLABORATION
INVESTORS
NOTICE
PRESENTATION
GENERAL MEETING
OF STOCKHOLDERS
INDEPENDENT
AUDITOR'S REPORT
CONTACT IR
MEDIA
NEWS
VIDEO SOURCE
ESG
OVERVIEW
ENVIRONMENTAL
SOCIAL
GOVERNANCE
NEWS
HOME
MEDIA
NEWS
NEWS
All
Press Release
News Update
Quarterly update
Total
10
10
News Update
First Patient Dosed in Phase II Study of NeoImmuneTech’s NT-I7 plus Pembrolizumab in Recurrent Glioblastoma
2023-02-07
9
News Update
Pharmaphorum highlights NeoImmuneTech
2022-12-19
8
News Update
NeoImmuneTech to Present at 2023 Biotech Showcase
2022-12-15
7
News Update
NeoImmuneTech Joins the United Nations Global Compact
2022-10-11
6
News Update
NeoImmuneTech to Present at Cytokine-Based Drug Development Summit
2022-07-26
5
News Update
Interest of Combining NeoImmuneTech’s Lead Asset NT-I7 (efineptakin alfa) with Pembrolizumab keeps Growing
2022-07-04
4
News Update
NeoImmuneTech to Display its Environmental, Social, and Governance Activities on its Corporate Website
2022-06-30
3
News Update
NeoImmuneTech to Present at Immuno-Oncology Summit Europe 2022
2022-05-19
2
News Update
NeoImmuneTech Received U.S. FDA Clearance of IND Application for Phase II Study of NT-I7 and Pembrolizumab in Recurrent Glioblastoma
2022-05-11
1
News Update
NeoImmuneTech to Celebrate First Year of Trading at KOSDAQ
2022-03-16
1
Search